# Autolus Therapeutics plc: filings

AUTL · Nasdaq · CIK 1730463 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/autl.md) · [Financials](/companies/autl/financials.md) · [Filings](/companies/autl/filings.md) · [Insiders](/companies/autl/insiders.md)

## Reports and events: 133 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (6-K 51, 8-K 46, SC 13G/A 25, 3 21, CORRESP 17, UPLOAD 17, SC 13G 15, EFFECT 12, SC 13D/A 12, 424B3 11, SCHEDULE 13G/A 11, 4 10, 424B5 10, 10-Q 9, 20-F 6, S-8 5, F-3 4, 10-K 3, DEL AM 3, F-1/A 3, S-3 3, SC 13D 3, 144 2, 424B4 2, 6-K/A 2, DRS 2, DRS/A 2, DRSLTR 2, F-1 2, F-1MEF 2, S-3ASR 2, SCHEDULE 13G 2, 20-F/A 1, 8-A12B 1, 8-K/A 1, CERT 1, CT ORDER 1, D 1, NT 10-Q 1, POS AM 1, POSASR 1, S-1 1, SCHEDULE 13D/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-28 | 21:08 ET | [SCHEDULE 13D/A](/filings/0001213900-26-095283.md) | Ownership report, active investor, amended | 0001213900-26-095283 |
| 2026-08-11 | 16:13 ET | [10-Q](/filings/0001730463-26-000123.md) | Quarterly report, period 2026-06-30 | 0001730463-26-000123 |
| 2026-08-11 | 07:33 ET | [8-K](/filings/0001730463-26-000119.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001730463-26-000119 |
| 2026-08-03 | 08:11 ET | [8-K](/filings/0001730463-26-000112.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001730463-26-000112 |
| 2026-08-03 | 07:00 ET | [8-K](/filings/0001193125-26-329526.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-26-329526 |
| 2026-06-29 | 16:03 ET | [8-K](/filings/0001730463-26-000072.md) | 5.07 Shareholder vote results | 0001730463-26-000072 |
| 2026-06-09 | 07:30 ET | [8-K](/filings/0001730463-26-000069.md) | 8.01 Other events | 0001730463-26-000069 |
| 2026-05-14 | 16:31 ET | [10-Q](/filings/0001730463-26-000065.md) | Quarterly report, period 2026-03-31 | 0001730463-26-000065 |
| 2026-05-14 | 07:53 ET | [8-K](/filings/0001730463-26-000058.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001730463-26-000058 |
| 2026-04-29 | 17:28 ET | [8-K](/filings/0001193125-26-192362.md) | 2.05 Exit or disposal costs; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-192362 |
| 2026-04-16 | 16:08 ET | [8-K](/filings/0001730463-26-000049.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001730463-26-000049 |
| 2026-04-08 | 16:17 ET | [8-K](/filings/0001730463-26-000043.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001730463-26-000043 |
| 2026-03-27 | 16:39 ET | [10-K](/filings/0001730463-26-000038.md) | Annual report, period 2025-12-31 | 0001730463-26-000038 |
| 2026-03-27 | 08:02 ET | [8-K](/filings/0001730463-26-000032.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001730463-26-000032 |
| 2026-01-26 | 16:07 ET | [8-K](/filings/0001730463-26-000019.md) | 1.01 Entry into a material agreement | 0001730463-26-000019 |
| 2026-01-12 | 08:36 ET | [8-K](/filings/0001730463-26-000012.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001730463-26-000012 |
| 2025-12-02 | 16:49 ET | [8-K](/filings/0001730463-25-000095.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure | 0001730463-25-000095 |
| 2025-11-12 | 16:22 ET | [10-Q](/filings/0001730463-25-000088.md) | Quarterly report, period 2025-09-30 | 0001730463-25-000088 |
| 2025-11-12 | 08:13 ET | [8-K](/filings/0001730463-25-000081.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001730463-25-000081 |
| 2025-08-12 | 16:12 ET | [10-Q](/filings/0001730463-25-000067.md) | Quarterly report, period 2025-06-30 | 0001730463-25-000067 |
| 2025-08-12 | 08:11 ET | [8-K](/filings/0001730463-25-000064.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001730463-25-000064 |
| 2025-06-27 | 08:47 ET | [8-K](/filings/0001730463-25-000046.md) | 5.07 Shareholder vote results | 0001730463-25-000046 |
| 2025-06-02 | 16:07 ET | [8-K](/filings/0001730463-25-000043.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001730463-25-000043 |
| 2025-05-30 | 16:06 ET | [8-K](/filings/0001193125-25-132111.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-132111 |
| 2025-05-08 | 17:08 ET | [S-1](/filings/0001193125-25-116059.md) | Registration statement | 0001193125-25-116059 |
| 2025-05-08 | 16:12 ET | [10-Q](/filings/0001730463-25-000039.md) | Quarterly report, period 2025-03-31 | 0001730463-25-000039 |
| 2025-05-08 | 08:04 ET | [8-K](/filings/0001730463-25-000032.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001730463-25-000032 |
| 2025-04-23 | 06:26 ET | [8-K](/filings/0001730463-25-000022.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001730463-25-000022 |
| 2025-04-03 | 16:05 ET | [8-K](/filings/0001193125-25-072356.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-25-072356 |
| 2025-03-20 | 16:33 ET | [10-K](/filings/0001730463-25-000019.md) | Annual report, period 2024-12-31 | 0001730463-25-000019 |
| 2025-03-20 | 07:09 ET | [8-K](/filings/0001730463-25-000010.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001730463-25-000010 |
| 2025-01-13 | 06:47 ET | [8-K](/filings/0001730463-25-000004.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001730463-25-000004 |
| 2024-11-12 | 16:27 ET | [10-Q](/filings/0001730463-24-000136.md) | Quarterly report, period 2024-09-30 | 0001730463-24-000136 |
| 2024-11-12 | 07:54 ET | [8-K](/filings/0001730463-24-000132.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001730463-24-000132 |
| 2024-11-12 | 06:56 ET | [8-K](/filings/0001730463-24-000129.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001730463-24-000129 |
| 2024-10-25 | 16:01 ET | [SC 13D/A](/filings/0001213900-24-090768.md) | Ownership report, active investor, amended | 0001213900-24-090768 |
| 2024-09-26 | 07:00 ET | [8-K](/filings/0001730463-24-000110.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001730463-24-000110 |
| 2024-09-19 | 08:09 ET | [8-K](/filings/0001730463-24-000104.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001730463-24-000104 |
| 2024-09-13 | 09:08 ET | [8-K](/filings/0001730463-24-000099.md) | 1.01 Entry into a material agreement | 0001730463-24-000099 |
| 2024-08-08 | 16:21 ET | [10-Q](/filings/0001730463-24-000093.md) | Quarterly report, period 2024-06-30 | 0001730463-24-000093 |
| 2024-08-08 | 08:27 ET | [8-K](/filings/0001730463-24-000088.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001730463-24-000088 |
| 2024-06-28 | 16:04 ET | [8-K](/filings/0001730463-24-000076.md) | 5.07 Shareholder vote results | 0001730463-24-000076 |
| 2024-06-05 | 16:35 ET | [8-K](/filings/0001730463-24-000074.md) | 8.01 Other events | 0001730463-24-000074 |
| 2024-06-03 | 17:15 ET | [8-K](/filings/0001730463-24-000070.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001730463-24-000070 |
| 2024-05-17 | 16:39 ET | [10-Q](/filings/0001730463-24-000064.md) | Quarterly report, period 2024-03-31 | 0001730463-24-000064 |
| 2024-05-17 | 08:27 ET | [8-K](/filings/0001730463-24-000059.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001730463-24-000059 |
| 2024-05-13 | 07:23 ET | [8-K](/filings/0001193125-24-136696.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-136696 |
| 2024-04-01 | 07:06 ET | [8-K](/filings/0001730463-24-000050.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001730463-24-000050 |
| 2024-03-25 | 16:10 ET | [SC 13D/A](/filings/0001213900-24-025536.md) | Ownership report, active investor, amended | 0001213900-24-025536 |
| 2024-03-21 | 16:55 ET | [10-K](/filings/0001730463-24-000048.md) | Annual report, period 2023-12-31 | 0001730463-24-000048 |

Page 1 of 3. [Older](/companies/autl/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.